Veranex has acquired IMMR
|Deal Type||Mergers & Acquisitions|
|Client & Transactional Partners||
|Our Role||Buy-Side Advisor|
Cain Brothers, a division of KeyBanc Capital Markets, in partnership with Clearwater International, a leading global mid-market corporate and advisory firm with offices across Europe and Asia, successfully co-advised Veranex on the acquisition of IMMR.
Veranex is the only truly comprehensive, global, tech-enabled service provider dedicated to the medical technology industry. Offering expert guidance from concept through to commercialization and across the development continuum, Veranex enables accelerated speed to market, controlled development costs, development risk mitigation, and accelerated market viability assessment. At every stage, Veranex customers realize efficiencies in cost and time, while its integrated and comprehensive solutions unify the entire development process.
Founded in 1984, Summit Partners is a global alternative investment firm that is currently managing more than $28 billion in capital dedicated to growth equity, fixed income and public equity opportunities. Summit Partners invests across growth sectors of the economy and has invested in more than 500 companies in healthcare and life sciences, technology and other growth industries.
IMMR is a leading preclinical science organization that provides preclinical research, pathology evaluation and surgical training services to medical technology innovators. Its in-house expertise and state-of-the-art, FDA-inspected and validated facilities are unparalleled for successfully completing sophisticated studies with novel interventional or surgical technologies.